Phlebotomists
Scrub through 96years of this role's history, from when it first emerged, through every wave of technology that reshaped it, to the cited projections for where it's heading next.
Vitestro raises a $70 million Series B to fund US pivotal clinical trials of the Aletta autonomous robotic phlebotomy device at Northwestern Medicine, Mayo Clinic, and Baylor Scott and White. The device is CE-marked in Europe and reports a 95% first-stick success rate. The trials represent the first serious commercial attempt to bring a fully autonomous venipuncture device into mainstream US clinical use, and their outcome will be a significant data point for the long-term trajectory of the human phlebotomist role.
The tools that defined the work
Select an era to see how it reshaped the work.
Manual venipuncture with reusable glass syringes and needles
Through the 1940s and into the 1950s, blood was drawn using glass syringes with reusable steel needles that had to be sterilized between patients by boiling or autoclaving. The phlebotomist's skill resided entirely in the manual act: vein selection by palpation, angle of entry, back-pressure control to avoid hemolysis, and the social skill of calming anxious patients. There were no standardized collection tubes, no vacuum systems, and no chain-of-custody documentation beyond a handwritten requisition slip. The risk of disease transmission via inadequately sterilized needles was real and not yet fully understood.
Work toolChanging equipment BD Vacutainer evacuated tube system (commercialized 1957)
The evacuated blood-collection tube, invented by Joseph Kleiner in the 1940s and commercialized by Becton Dickinson as the Vacutainer system starting in the late 1940s and reaching widespread hospital adoption by the late 1950s, transformed the mechanics of phlebotomy. A pre-evacuated glass tube with a rubber stopper replaced the push-pull syringe: blood flowed by vacuum into the tube without the collector needing to maintain a plunger. Multiple tubes could be drawn from a single venipuncture using a dual-ended needle and a holder, reducing the number of patient sticks needed for a multi-test order. The Vacutainer separated the skill of needle placement from the mechanical management of specimen volume, making it possible to train non-nurses to reliably collect blood at scale.
Effect on the workThe Vacutainer system is widely credited among clinical laboratory historians as the enabling technology for the standalone phlebotomist role: it standardized collection enough that dedicated, specifically trained non-nurses could reliably perform it, reducing the cost of specimen collection and enabling the high-throughput models that reference laboratories would later require.
Work toolChanging equipment Formal phlebotomy certification (ASCP 1975, NPA 1978) and tube-color standardization
The founding of phlebotomy-specific certification programs in the mid-1970s was a technology of knowledge organization as much as equipment. The ASCP Board of Certification introduced the phlebotomy technician credential in 1975, establishing for the first time a formal competency standard for the role. National standardization of tube-top color codes (red for serum chemistry, lavender for CBC with EDTA anticoagulant, blue for coagulation studies, green for plasma heparinized) created a shared visual language that reduced pre-analytical errors and made phlebotomy procedures transferable between institutions. The NPA's founding in 1978 and the National Credentialing Agency for Laboratory Personnel's entry in 1989 created a competitive multi-credentialing landscape that persists today.
Work toolChanging equipment Plastic Vacutainer tubes + retractable safety needles (OSHA Needlestick Safety Act 2000)
Two safety advances reshaped the physical toolkit of phlebotomy in the 1980s and 1990s. First, glass Vacutainer tubes were progressively replaced by plastic tubes (BD introduced plastic Vacutainers in the 1980s), eliminating the risk of tube breakage and glass-related needlestick injuries while reducing shipping weight for reference laboratories. Second, the Needlestick Safety and Prevention Act of 2000 mandated that employers use safer needle designs where feasible, driving rapid adoption of retractable-needle and needle-shielding devices for phlebotomy. BD's Eclipse needle (retractable shielding) and similar devices became standard issue. The 2000 Act also required employers to solicit frontline healthcare workers' input on safety device selection, making phlebotomists active participants in equipment specification.
Effect on the workNeedlestick injury rates in healthcare workers fell by approximately 31-38% in the decade following the 2000 Act, according to CDC surveillance data. Phlebotomists and nurses were the occupational groups with the highest needlestick incidence prior to the mandate; the safety-needle transition substantially reduced this occupational hazard.
Work toolChanging equipment Electronic health records and barcode positive patient identification (PPID)
The HITECH Act of 2009 and subsequent Medicare/Medicaid incentive payments accelerated mass adoption of electronic health records across US hospitals. For phlebotomists, EHR integration introduced the barcode-based positive patient identification workflow: at the bedside, the phlebotomist scans the patient's wristband and the requisition barcode to electronically confirm identity before drawing, and the LIS prints a matching label that travels with the tube. This workflow, pioneered by Epic's Beaker LIS and Rover mobile app, dramatically reduced specimen mislabeling, which had historically been one of the most common and dangerous pre-analytical laboratory errors. Epic Rover enabled the phlebotomist to carry the entire collection workflow on a handheld device: order retrieval, patient verification, label printing, and real-time specimen tracking.
Effect on the workSpecimen labeling errors fell substantially at institutions implementing PPID workflows. A 2012 study in the American Journal of Clinical Pathology found that barcode-assisted PPID reduced wrong-blood-in-tube events by over 50% at implementing institutions, improving patient safety while adding a documentation workload component to the phlebotomist's role.
Electronic recordDigital charting Near-infrared vein visualization devices (AccuVein AV300 2008, AV400 2012)
Near-infrared vein visualization devices, led by AccuVein (founded 2005; AV300 cleared 2008, AV400 2012, AV500 2015), project a real-time map of subcutaneous veins directly onto the skin surface. The technology uses infrared light absorbed by hemoglobin to create a live map of the vein network, allowing the phlebotomist to identify veins that are invisible and non-palpable on difficult-access patients: children, elderly patients with fragile veins, obese patients, oncology patients with chronic IV access, and patients with chronic illness-related vascular changes. AccuVein published data showing an 18% improvement in first-attempt success rates in documented difficult-venous-access cases. These devices do not automate the venipuncture itself; they augment the human's visual information, improving skill outcomes on the cases that most frequently require multiple attempts.
Effect on the workVein visualization adoption has been concentrated in pediatric, oncology, and emergency settings where difficult access is most common. The devices reduced patient discomfort and time per difficult draw, improving throughput on the most time-consuming cases without reducing overall phlebotomist staffing needs.
Work toolChanging equipment Mobile phlebotomy platforms and at-home blood collection services (Getlabs, Scarlet Health, Dispatch Health)
The COVID-19 pandemic accelerated demand for at-home and mobile phlebotomy as patients avoided clinical settings and telehealth visits multiplied. Startups including Getlabs (founded 2019), Scarlet Health (backed by Quest Diagnostics, launched 2021), and LetsGetChecked expanded the phlebotomist's workplace from the hospital or laboratory drawing station to the patient's home, workplace, or hotel. Dispatch Health integrated mobile phlebotomy into its acute-care-at-home model. These platforms use scheduling apps, GPS dispatch, and mobile LIS connectivity to replicate the specimen chain-of-custody workflow in non-clinical settings. Mobile phlebotomy represents a structural expansion of the role rather than a displacement: new employer types emerged, but the core venipuncture skill remained unchanged.
Work toolChanging equipment Robotic phlebotomy prototypes under clinical evaluation (Vitestro Aletta, Rutgers Veebot)
Autonomous robotic phlebotomy devices entered clinical trials in the mid-2020s. Vitestro's Aletta device, CE-marked in Europe, uses near-infrared and ultrasound imaging to locate veins and performs the full venipuncture sequence autonomously with a reported 95% first-attempt success rate. As of 2025, Aletta was in pivotal US clinical trials at Northwestern Medicine, Mayo Clinic, and Baylor Scott and White after Vitestro raised a $70 million Series B in 2026. Rutgers University's Veebot prototype, an earlier academic effort, demonstrated robot-executed venipuncture in laboratory settings but did not advance to commercial deployment. These devices represent a real long-term scenario for routine low-complexity draws in high-volume settings. The barriers to widespread deployment include FDA clearance, capital cost per installation, patient acceptance of non-human needle insertion, and the irreducibly human component of patient communication and anxiety management, which the robotic devices do not address.
Work toolChanging equipment
What credible sources project
Scrub the slider past now to anchor each scenario on the scrubber. The spread is the range of futures credible sources project for this role.
What's shifting in the work right now
The historical view above shows how this role has moved. This is the present-day detail: which AI tools are picking up which tasks, where the edge still is, and the natural directions this work can grow.
What's changing in your day
Three parts of your work where AI is already doing real lifting, and what stays yours.
AI is sitting alongside you herePrint and affix specimen labels, log collection times, and document chain-of-custody in the laboratory information system (LIS), ensuring the specimen tracker shows real-time location from bedside through analysis.
Print and affix specimen labels, log collection times, and document chain-of-custody in the laboratory information system (LIS), ensuring the specimen tracker shows real-time location from bedside through analysis.[6]
Learn LIS-level audit-trail features; understand how AI-powered anomaly detection in modern LIS platforms flags mislabeled or improperly timed specimens so you can correct at source.
AI is sitting alongside you hereConfirm patient identity via two-factor positive patient identification (PPID): name-plus-date-of-birth verbal check and barcode wristband scan, before every collection event using the EHR mobile app (e.g., Epic Rover).
Confirm patient identity via two-factor positive patient identification (PPID): name-plus-date-of-birth verbal check and barcode wristband scan, before every collection event using the EHR mobile app (e.g., Epic Rover).[6],[2]
Complete Epic Rover or equivalent mobile-LIS training; champion PPID compliance as a quality metric, as AI-flagged mislabel events increasingly route to human review.
AI is sitting alongside you hereTriage and escalate specimen-quality rejections: recognize hemolysis, clotting, incorrect tube type, or insufficient volume before the sample reaches the analyzer, and re-collect or communicate recollection instructions to the ordering provider.
Triage and escalate specimen-quality rejections: recognize hemolysis, clotting, incorrect tube type, or insufficient volume before the sample reaches the analyzer, and re-collect or communicate recollection instructions to the ordering provider.[7]
Learn the pre-analytical error taxonomy and how AI-powered analyzer interfaces auto-reject substandard samples; position yourself as the human who prevents recollects by catching errors at the source.
Where this role is heading
Natural next steps for someone with your foundation: not exits, evolutions.
Medical and Clinical Laboratory Technicians
Phlebotomists already operate within the clinical lab workflow and understand specimen integrity. An associate degree in clinical laboratory science plus ASCP MLT certification adds analytical bench skills (urinalysis, CBC interpretation, microbiology) and opens higher-paying, more AI-augmented roles with broader automation upside.
- · Clinical laboratory science coursework (associate degree or certificate)
- · ASCP MLT or AMT MLT certification
- · Hematology and urinalysis analyzer operation
- · Quality-control documentation and CLIA compliance
See the same long-arc view for your own profession.
Browse the directory by industry, or search by title or SOC code. New roles ship every few weeks. Every profile cites every claim.
Browse all roles